, Tracking Stock Market Picks
Enter Symbol:
Rating: OMED

Oncomed Pharmaceuticals Inc. (NASDAQ: OMED) rated to Overweight by Piper Jaffray

Monday,  Aug 12, 2013  8:25 AM ET by Kristen Bailey

Piper Jaffray rated
Oncomed Pharmaceuticals Inc. (NASDAQ: OMED) to Overweight.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy